000 | 01819 a2200493 4500 | ||
---|---|---|---|
005 | 20250517100626.0 | ||
264 | 0 | _c20170308 | |
008 | 201703s 0 0 eng d | ||
022 | _a1618-0607 | ||
024 | 7 |
_a10.1016/j.ijmm.2016.05.010 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKaku, Norihito | |
245 | 0 | 0 |
_aAntimicrobial and immunomodulatory effects of tedizolid against methicillin-resistant Staphylococcus aureus in a murine model of hematogenous pulmonary infection. _h[electronic resource] |
260 |
_bInternational journal of medical microbiology : IJMM _cSep 2016 |
||
300 |
_a421-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
650 | 0 | 4 | _aBacterial Load |
650 | 0 | 4 |
_aCytokines _xblood |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aImmunologic Factors _xadministration & dosage |
650 | 0 | 4 |
_aLung _xmicrobiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethicillin-Resistant Staphylococcus aureus _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aOrganophosphates _xadministration & dosage |
650 | 0 | 4 |
_aOxazoles _xadministration & dosage |
650 | 0 | 4 |
_aPlasma _xchemistry |
650 | 0 | 4 |
_aPneumonia, Staphylococcal _xdrug therapy |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aMorinaga, Yoshitomo | |
700 | 1 | _aTakeda, Kazuaki | |
700 | 1 | _aKosai, Kosuke | |
700 | 1 | _aUno, Naoki | |
700 | 1 | _aHasegawa, Hiroo | |
700 | 1 | _aMiyazaki, Taiga | |
700 | 1 | _aIzumikawa, Koichi | |
700 | 1 | _aMukae, Hiroshi | |
700 | 1 | _aYanagihara, Katsunori | |
773 | 0 |
_tInternational journal of medical microbiology : IJMM _gvol. 306 _gno. 6 _gp. 421-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijmm.2016.05.010 _zAvailable from publisher's website |
999 |
_c26089194 _d26089194 |